METTL1 and hepatocellular carcinoma: Furthermore, further studies by the same team indicated that METTL1-mediated tRNA m7G modification could facilitate post-RFA HCC metastasis by inducing translation of SNAI1 and SLUG, which provide potential therapy target to decrease recurrence rate 177.